Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Alitretinoin
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable
Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 20, 2017
Lead Product(s) : Alitretinoin
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : ZonMw
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Alitretinoin
Therapeutic Area : Immunology
Study Phase : Phase II
Sponsor : Basilea Pharmaceutica
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 02, 2011
Lead Product(s) : Alitretinoin
Therapeutic Area : Immunology
Highest Development Status : Phase II
Sponsor : Basilea Pharmaceutica
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Alitretinoin
Therapeutic Area : Dermatology
Study Phase : Phase II
Sponsor : Basilea Pharmaceutica
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 22, 2010
Lead Product(s) : Alitretinoin
Therapeutic Area : Dermatology
Highest Development Status : Phase II
Sponsor : Basilea Pharmaceutica
Deal Size : Inapplicable
Deal Type : Inapplicable